Sunday, March 25, 2012

EBF 5th Open: Mark your Calendars!

European Bioanalysis Forum
5th Open Symposium

Mark your Calendars!

November 14-16, 2012

EBF will organize its 5th Open Symposium on regulated bioanalysis

Old Battles and New Horizons

at the Hesperia Tower Conference Center, Barcelona, Spain.

The conference will bring together leaders in industry (Pharma and CRO), academia, quality assurance and regulatory authorities to discuss established concepts and recent thinking on regulated bioanalysis. The scientific program is currently under development and will comprise of presentations by and discussions with experts from around the globe. The conference program will include topics as:

Tiered approach in practice - are our minds ready for it? # Bioanalysis and Toxicokinetics, or how to marry GLP and science # "Oral Posters session" # A progress update since Large meets Small # Technology updates # Micro sampling - updates on DBS & recent developments # Large molecule/LBA dedicated sessions # Electronic raw data and Electronic Lab Notebook (ELN) # Is quantitative bioanalysis ready for HR/MS  # Young Scientist Award # BA clinics - consult the doctor (Breakout) # Global Harmonization: has the dust settled? And "updates from the globe" # Challenges in global clinical studies

EBF invites scientist who are considering to present their work at our meeting to submit their oral presentation and/or poster to the conference email account:

The dedicated conference site: will go live this month. Visit the site for further announcements and details on the meeting, venue and registration. 

Saturday, March 3, 2012

EBF Focus Meeting - Second Call for Speakers & Posters

Second Call for Speakers & Posters

European Bioanalysis Forum
3rd Focus Meeting – “Hatching”

Emerging Technologies Approaching the
Regulated Bioanalysis Laboratory

With scientific developments and regulatory expectations not always in concert, our 3rd Focus Meeting aims to connect on the potential of a broad array of new technologies. We will provide a scientific hub for the development of strategies, which may enable the application of these emerging technologies to their full potential in regulated bioanalysis.
Each session intends to have 4 speakers (1 keynote of 30 minutes and 3 contributions of 20 minutes). For details on the goals and objectives of each session, please visit the conference website at
Potential speakers, please submit the title and abstract of your presentation before 31 March 2012 to conference address:, attaching a filled out oral presentation submission form available on the conference website. Acceptance of your presentation will be communicated before 15 April 2011.
There will be room for approx. 30 posters and in principle all submitted posters will be accepted. Please submit the title and abstract of your poster before 15 May 2012 to conference address:, attaching a filled out poster presentation submission form available on the conference website. Supported poster format is portrait (size A0).
Day 1 - 12 June 2012
Morning plenary sessions: What's new in Sample Enrichment Technology
Session 1 - Miniaturization and/or automation of sample preparation techniques
This session will focus on recent progress made in automation and/or miniaturization in support of (regulated) bioanalytical sample preparation. This includes but is not limited to liquid handling technologies, micro extraction and chip technologies. The goal of this session is to share and discuss techniques and processes that will facilitate the sample preparation workflow.
Session 2 - How can antibody technology help with sample enrichment for NCE or peptides quantification?
This session will focus the use of antibody capture techniques used to optimise sample enrichment for Pharmocokinetic and Pharmacodynamic endpoint technologies.

Afternoon plenary sessions: Recent developments in tissue analysis
Session 3 - Tissue analysis (including micro sampling) and PK/PD
Over the last years, the analytical potential offered by modern MS technology or  immunological approaches opened new avenues in the analysis of non standard matrices for PK, TK or PK/PD reasons. In this session we invite scientist to share their experience or observed scientific, analytical or regulatory hurdles when applying these new technologies. Both MS and LBA scientist will be welcomed.
Session 4 - Is Tissue Imaging approaching quantitative bioanalysis expectations
The goal of this session is to highlight & discuss the advances and current/potential future use of Tissue Imaging approaches as quantitative bioanalytical tools in a regulated environment.
Day 2 - 13 June 2012
Morning breakout sessions: Miniaturization and diversification in LC – MS interfacing
Session 5 - Miniaturization of LC using ‘conventional’ MS Ionization techniques
Advances made in LC miniaturization, such as microbore and capillary LC, CE, and chip techniques, is opening new possibilities for the bioanalytical scientist. Together with these new possibilities come new challenges. In this session, thoughts and experiences with these techniques will be shared with the aim to enhance the toolset in the (regulated) bioanalytical laboratory and improve problem solving capability.
Session 6 - Alternative MS-interfaces for quantitative bioanalysis
The last 5 years may have been one of the most exciting periods for the bioanalytical scientist with (historically less robust) alternative MS-interfaces  (to the commonly used ESI and APCI) coming available to their fullest potential for quantitative bioanalysis. In this session, we aim at providing examples of these alternative MS-interfaces and want to stimulate discussions to enhance their application in (regulated) quantitative bioanalysis.
Morning Breakout Sessions: Emerging platforms in support of LBA
Session 7 - Recent new technologies – Methodologies
As the industry looks at options beyond traditional single-plate ELISAs  to achieve greater dynamic ranges, analyze multiple analytes or exploit new reporting systems; what are the technology options available (e.g. Flow Cytometry, multiplex analysers etc)? The goal of this session is to showcase & discuss the emerging new LBA technologies & novel LBA methodologies for use in a regulated bioanalysis setting.
Session 8 - Recent new technologies – Applications and validation approaches
How are methods being validated on new technology platforms? This session aims to identify and discuss best practices for the validation package requirements of novel LBA applications - are these bespoke or can traditional ELISA method validation packages be used?
Afternoon plenary session: Global Bioanalysis Consortium Updates
Session 9 - GBC feedback session
Discuss and provide feedback on the progress made in global harmonization of the bioanalysis guidelines (GBC). The intention is to invite 4-5 Harmonization team leads (or a regional representative from those teams) to present the progress of their teams and to engage with delegates for input and feedback.